Shareholding Pattern For June 30, 2014
Wanbury Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.18-07-2014
18-07-2014
Financial Results & Limited Review for March 31, 2014
Wanbury Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended March 31, 2014.12-05-2014
Shareholding Pattern for March 31, 2014
Wanbury Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March 31, 2014.15-04-2014
Extension of Current Accounting Year
Wanbury Ltd has informed BSE that the Company' Current Accounting Year has been extended and now it will be for 18 months from 1st April, 2013 to 30th September, 2014 instead of 12 months from 1st April, 2013 to 31st March, 2014.Therefore the Company will submit to Stock Exchange Unaudited Financial Results for the quarter ending on 31st March, 2014 & 30th June, 2014 and Annual Audited Financial Results for 18 months from 1st April, 2013 to 30th September, 2014....24-03-2014
Financial Results & Limited Review for Dec 31, 2013
Wanbury Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.11-02-2014
Financial Results & Limited Review for Sept 30, 2013
Wanbury Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013.14-11-2013
Insolvency Petition filed in the Commercial Courts of Madrid, Spain by Cantabria Pharma S. L., subsidiary of the Company
Wanbury Ltd has informed BSE that Cantabria Pharma S.L., Spain, subsidiary of the Company has filed petition for voluntary insolvency in the Commercial Courts of Madrid, Spain on November 04, 2013.07-11-2013
Updates on Outcome of AGM
Wanbury Ltd has submitted to BSE a copy of minutes of the 25th Annual General Meeting held on September 24, 2013.09-10-2013
Classification of manufacturing facilities as Acceptable by Department of Health & Human Services, U.S.A.
Wanbury Ltd has informed BSE that the Company's manufacturing facilities at Patalganga and Tanaku have been classified as acceptable by the Department of Health & Human Services, Public Health Service, Food and Drug Administration, U.S.A. (US FDA).26-09-2013
Outcome of AGM
Wanbury Ltd has informed BSE that the 25th Annual General Meeting (AGM) of the Company was held on September 24, 2013.24-09-2013